S. Hitchcock-bryan

发表

The impact of induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia.

R. Gelber, S. Sallan, J. Cassady, 1986, Medical and pediatric oncology.

Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia.

S. Sallan, C. Niemeyer, S. Sallan, 1985, Seminars in oncology.

Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.

R. Gelber, S. Sallan, J. Cassady, 1983, Cancer research.

Efficacy and morbidity of central nervous system prophylaxis in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate

J. Belli, S. Sallan, J. Cassady, 1983 .

Efficacy and morbidity of central nervous system "prophylaxis" in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate.

M. Grever, J. Belli, S. Sallan, 1983, Blood.

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

R. Gelber, S. Sallan, N. Tarbell, 1986, The New England journal of medicine.

Relapse in childhood acute lymphoblastic leukemia after elective cessation of initial treatment: failure of subsequent treatment with cyclophosphamide, cytosine arabinoside, vincristine and prednisone (COAP).

S. Sallan, S. Hitchcock-bryan, 1981, Medical and pediatric oncology.

A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of c-Met and Vascular Endothelial Growth Factor Receptor 2

G. Shapiro, A. Zhu, E. Heath, 2010, Clinical Cancer Research.

“Entering a clinical trial: Is it right for you?”

S. Joffe, S. Bauer-Wu, S. Hitchcock-bryan, 2012, Cancer.